


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31198928</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-2651</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biochemistry</Title>
                <ISOAbbreviation>J. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Production and characterization of monoclonal antibodies against the DNA binding domain of the RE1-Silencing Transcription factor.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">mvz046</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/jb/mvz046</ELocationID>
            <Abstract>
                <AbstractText>The use of monoclonal antibodies for detection of cellular biomarker during carcinogenesis provides new strategies for the diagnostic or prognostic of cancer in patients. The loss of the Restrictive Element 1-Silencing Transcription (REST) factor have been observed in previous molecular and immunological approaches in aggressive breast cancer, small cell lung cancer, liver carcinoma and colo-rectal cancer; however, in the clinic diagnostic there are not available monoclonal antibodies for REST recognition. The goal of this work was to design, produce and characterize monoclonal antibodies against the DNA Binding Domain (DBD) of REST suitable for immunoassays. We looked for conserved domains, and immunogenic and antigenic sites in REST structure through in silico analysis. For mice immunization, we used recombinant DBD of REST purified by affinity chromatography, and then hybridomes were generated by mouse spleen fusion with myeloma cells. Finally, for monoclonal antibody characterization we performed ELISA, Western Blot, Dot blot Immunocytochemistry and Immunoprecipitation assays. Results showed that DBD is conserved in REST isoforms and contains immunogenic and antigenic sites. We generated three clones producing monoclonal antibodies against DBD of REST, one of them specifically recognized native REST and was suitable for Immunocytochemistry in samples from patients.</AbstractText>
                <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cortés-Sarabia</LastName>
                    <ForeName>Karen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas s/n, Chilpancingo, Guerrero, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Medina-Flores</LastName>
                    <ForeName>Yolanda</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Instituto de Diagnóstico y Referencia Epidemiológicos &quot;Dr. Manuel Martínez Báez&quot;. Francisco de P. Miranda 177, Lomas de Plateros, Ciudad de México, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alarcón-Romero</LastName>
                    <ForeName>Luz Del Carmen</ForeName>
                    <Initials>LDC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas s/n, Chilpancingo, Guerrero, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mata-Ruíz</LastName>
                    <ForeName>Olga</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Instituto de Diagnóstico y Referencia Epidemiológicos &quot;Dr. Manuel Martínez Báez&quot;. Francisco de P. Miranda 177, Lomas de Plateros, Ciudad de México, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vences-Velázquez</LastName>
                    <ForeName>Amalia</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas s/n, Chilpancingo, Guerrero, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodríguez-Ruíz</LastName>
                    <ForeName>Hugo Alberto</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas s/n, Chilpancingo, Guerrero, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valdés</LastName>
                    <ForeName>Jesús</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Bioquímica. Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional. Av. Instituto Politécnico Nacional 2508. Ciudad de México, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ortuño-Pineda</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas s/n, Chilpancingo, Guerrero, México.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Biochem</MedlineTA>
            <NlmUniqueID>0376600</NlmUniqueID>
            <ISSNLinking>0021-924X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">DNA binding domain</Keyword>
            <Keyword MajorTopicYN="N">NRSF</Keyword>
            <Keyword MajorTopicYN="N">REST</Keyword>
            <Keyword MajorTopicYN="N">immunoassays</Keyword>
            <Keyword MajorTopicYN="N">monoclonal antibodies</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31198928</ArticleId>
            <ArticleId IdType="pii">5518926</ArticleId>
            <ArticleId IdType="doi">10.1093/jb/mvz046</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

